Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and Immunization
Patients with hematological conditions are particularly vulnerable to HZ. Effective prevention requires a tailored combination of antiviral prophylaxis and aRZV immunization. The development of mRNA-based vaccines may further enhance preventive strategies for this at-risk population.
Authors
- Caterina Labanca (ORCID: https://orcid.org/0000-0001-9985-1005)
- Enrica Antonia Martino (ORCID: https://orcid.org/0000-0002-8504-3231)
- Massimo Gentile (ORCID: https://orcid.org/0000-0002-5256-0726)
- Fortunato Morabito (ORCID: https://orcid.org/0000-0002-2585-7073)
- Antonella Bruzzese (ORCID: https://orcid.org/0000-0002-9456-2404)
- Santino Caserta (ORCID: https://orcid.org/0000-0002-0698-1781)
- Virginia Olivito
- Francesco Mendicino (ORCID: https://orcid.org/0000-0001-6339-632X)
- Ernesto Vigna (ORCID: https://orcid.org/0000-0002-2123-6683)
- Nicola Amodio (ORCID: https://orcid.org/0000-0002-1345-4410)
- Eugenio Lucia
Institutions
- Magna Graecia University (IT)
- Azienda Ospedaliera di Cosenza (IT)
- Ospedale Annunziata di Cosenza (IT)
- University of Calabria (IT)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1111/ejh.70049
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00